Search
Search Results
- Publication:
- [Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, March 2005
- Subject(s):
- Lens Implantation, Intraocular
Medical Errors -- prevention & control
Ophthalmologic Surgical Procedures
Checklist
Patient Safety
Time Out, Healthcare
Humans
Pennsylvania
United States
- Publication:
- [Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, March 2005
- Subject(s):
- Equipment and Supplies -- adverse effects
Equipment Failure
Equipment Safety
Medical Errors -- prevention & control
Circumcision, Male
Patient Safety
Sterilization -- methods
Humans
Pennsylvania
United States
- Publication:
- [Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, March 2005
- Subject(s):
- Anesthetics, Local -- adverse effects
Benzocaine -- adverse effects
Medication Errors -- prevention & control
Methemoglobinemia -- chemically induced
Anesthetics, Local -- administration & dosage
Benzocaine -- administration & dosage
Drug Overdose
Patient Safety
Humans
Pennsylvania
United States
- Publication:
- [Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, March 2005
- Subject(s):
- Abbreviations as Topic
Drug Prescriptions
Handwriting
Medication Errors -- prevention & control
Patient Safety
Prescription Drugs -- administration & dosage
Humans
Pennsylvania
United States
- Publication:
- [Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, March 2005
- Subject(s):
- Organizational Culture
Restraint, Physical -- adverse effects
Restraint, Physical -- utilization
Social Isolation
Inservice Training
Mental Disorders -- therapy
Patient Safety
Humans
Pennsylvania
United States
- Publication:
- [Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, March 2005
- Subject(s):
- Surgical Procedures, Operative -- methods
Time Out, Healthcare
Patient Safety
Humans
Pennsylvania
United States
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, April 7, 2017
- Subject(s):
- Arthritis, Rheumatoid -- drug therapy
Arthritis, Rheumatoid -- immunology
Immunologic Factors -- therapeutic use
Abatacept -- therapeutic use
Adalimumab -- therapeutic use
Antirheumatic Agents -- adverse effects
Antirheumatic Agents -- therapeutic use
Certolizumab Pegol -- therapeutic use
Cost-Benefit Analysis
Drug Therapy, Combination
Etanercept -- therapeutic use
Immunologic Factors -- adverse effects
Infliximab -- therapeutic use
Interleukin-6 -- antagonists & inhibitors
Janus Kinase Inhibitors -- therapeutic use
Randomized Controlled Trials as Topic
Rituximab -- therapeutic use
Tumor Necrosis Factors -- antagonists & inhibitors
Humans
United States
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, June 8, 2017
- Subject(s):
- Antibodies, Monoclonal -- therapeutic use
Dermatitis, Atopic -- drug therapy
Interleukin-4 Receptor alpha Subunit -- antagonists & inhibitors
Phosphodiesterase 4 Inhibitors -- therapeutic use
Antibodies, Monoclonal -- adverse effects
Cost-Benefit Analysis
Cyclosporine -- therapeutic use
Phosphodiesterase 4 Inhibitors -- adverse effects
Phototherapy
Randomized Controlled Trials as Topic
Treatment Outcome
Humans
United States
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, July 17, 2017
- Subject(s):
- Anabolic Agents -- therapeutic use
Antibodies, Monoclonal, Humanized -- therapeutic use
Osteoporosis, Postmenopausal -- drug therapy
Parathyroid Hormone-Related Protein -- therapeutic use
Anabolic Agents -- adverse effects
Anabolic Agents -- economics
Antibodies, Monoclonal, Humanized -- adverse effects
Antibodies, Monoclonal, Humanized -- economics
Bone Density Conservation Agents -- adverse effects
Bone Density Conservation Agents -- economics
Bone Density Conservation Agents -- therapeutic use
Comparative Effectiveness Research
Diphosphonates -- adverse effects
Diphosphonates -- economics
Diphosphonates -- therapeutic use
Osteoporotic Fractures -- prevention & control
Parathyroid Hormone-Related Protein -- adverse effects
Parathyroid Hormone-Related Protein -- economics
Randomized Controlled Trials as Topic
Teriparatide -- adverse effects
Teriparatide -- economics
Teriparatide -- therapeutic use
Humans
United States
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, August 8, 2017
- Subject(s):
- Abuse-Deterrent Formulations -- economics
Abuse-Deterrent Formulations -- statistics & numerical data
Analgesics, Opioid -- economics
Analgesics, Opioid -- therapeutic use
Opioid-Related Disorders -- economics
Opioid-Related Disorders -- prevention & control
Prescription Drug Diversion -- statistics & numerical data
Comparative Effectiveness Research
Cost-Benefit Analysis
Delayed-Action Preparations -- economics
Delayed-Action Preparations -- therapeutic use
Drug Compounding -- economics
Drug Overdose -- mortality
Insurance Coverage -- economics
Insurance, Pharmaceutical Services -- economics
Opioid-Related Disorders -- epidemiology
Humans
United States
